Search

everythinglearnresearchcommunity

for

Search:↓

Birth control pills slightly increase the risk of breast cancer, especially if used before the first full-term pregnancy.

Hypertrichosis lanuginosa causes excessive fine hair growth, often linked to genetics or cancer, with limited treatment options.

Different types of long-lasting stem cells are responsible for the growth and upkeep of the mammary gland.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.

Melatonin affects many body functions beyond sleep by interacting with specific receptors in various tissues.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

Mouse skin has special cells in the epidermis that decrease with age and are linked to keratinocyte stem cells.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Evaluate postmenopausal women with high androgen levels using medical history, physical exams, lab tests, and imaging to manage health risks.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

A substance called Compound 2g can strongly block STS (a hormone-related enzyme) without affecting estrogen levels, making it potentially good for treating breast cancer.

SACUMAN, a rare condition causing hair loss without clear signs, is often misdiagnosed and needs scalp biopsies for accurate detection.

Hormone therapies like birth control pills and spironolactone are safe and effective for treating women's adult acne.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

Hormone therapy can improve mental health and quality of life for people with gender dysphoria, but long-term effects need more research.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Gender-affirming hormone therapy improves mental health and gender incongruence but requires careful management of cardiovascular and cancer risks.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

CCCA affects adolescents too, with genetic and environmental links, requiring careful diagnosis.

KLF4 is important for maintaining stem cells and has potential in cancer treatment and wound healing.

Testosterone patches can modestly improve sexual function in postmenopausal women not on estrogen therapy.

Misbehaving hair follicle stem cells can cause hair loss and offer new treatment options.